EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single-cell analysis reveals the COL11A1+ fibroblasts are cancer-specific fibroblasts that promote tumor progression

Jiayu Zhang, Shiqi Lu, Tong Lu, Donghui Han, Keying Zhang, Lunbiao Gan, Xinjie Wu, Yu Li, Xiaolong Zhao, Zhengxuan Li, Yajie Shen, Sijun Hu und 3 weitere

Frontiers in Pharmacology · 20.01.2023 · 14

DOI: 10.3389/fphar.2023.1121586 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 20.01.2023. Verfasst von Jiayu Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Xijing Hospital, Fourth Military Medical University, Xi'an, China. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Basic Research Program of Shaanxi Province, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer-associated fibroblasts (CAFs) promote tumor progression through extracellular matrix (ECM) remodeling and extensive communication with other cells in tumor microenvironment. However, most CAF-targeting strategies failed in clinical trials due to the heterogeneity of CAFs. Hence, we aimed to identify the cluster of tumor-promoting CAFs, elucidate their function and determine their specific membrane markers to ensure precise targeting.

Methods

We integrated multiple single-cell RNA sequencing (scRNA-seq) datasets across different tumors and adjacent normal tissues to identify the tumor-promoting CAF cluster. We analyzed the origin of these CAFs by pseudotime analysis, and tried to elucidate the function of these CAFs by gene regulatory network analysis and cell-cell communication analysis. We also performed cell-type deconvolution analysis to examine the association between the proportion of these CAFs and patients’ prognosis in TCGA cancer cohorts, and validated that through IHC staining in clinical tumor tissues. In addition, we analyzed the membrane molecules in different fibroblast clusters, trying to identify the membrane molecules that were specifically expressed on these CAFs.

Results

We found that COL11A1+ fibroblasts specifically exist in tumor tissues but not in normal tissues and named them cancer-specific fibroblasts (CSFs). We revealed that these CSFs were transformed from normal fibroblasts. CSFs represented a more activated CAF cluster and may promote tumor progression through the regulation on ECM remodeling and antitumor immune responses. High CSF proportion was associated with poor prognosis in bladder cancer (BCa) and lung adenocarcinoma (LUAD), and IHC staining of COL11A1 confirmed their specific expression in tumor stroma in clinical BCa samples. We also identified that CSFs specifically express the membrane molecules LRRC15, ITGA11, SPHK1 and FAP, which could distinguish CSFs from other fibroblasts.

Conclusion

We identified that CSFs is a tumor specific cluster of fibroblasts, which are in active state, may promote tumor progression through the regulation on ECM remodeling and antitumor immune responses. Membrane molecules LRRC15, ITGA11, SPHK1 and FAP could be used as therapeutic targets for CSF-targeting cancer treatment.

Schlagwörter

Stichwörter der Autor:innen

ECM remodelingcancer-associated fibroblastsimmune responsesingle-cell RNA sequencingtumor microenvironment

Autor:innen und Institutionen

  • Department of Urology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Institute of Medical Research, Northwestern Polytechnical University, Xi'an, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Basic Research Program of Shaanxi Province
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Zhang, J., Lu, S., Lu, T., Han, D., Zhang, K., Gan, L., Wu, X., Li, Y., Zhao, X., Li, Z., Shen, Y., Hu, S., Yang, F., Wen, W., & Qin, W. (2023). Single-cell analysis reveals the COL11A1+ fibroblasts are cancer-specific fibroblasts that promote tumor progression. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1121586

Vancouver

Zhang J, Lu S, Lu T, Han D, Zhang K, Gan L, et al. Single-cell analysis reveals the COL11A1+ fibroblasts are cancer-specific fibroblasts that promote tumor progression. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1121586

BibTeX
@article{Zhang2023,
  author = {Zhang, Jiayu and Lu, Shiqi and Lu, Tong and Han, Donghui and Zhang, Keying and Gan, Lunbiao and Wu, Xinjie and Li, Yu and Zhao, Xiaolong and Li, Zhengxuan and Shen, Yajie and Hu, Sijun and Yang, Fa and Wen, Weihong and Qin, Weijun},
  title = {Single-cell analysis reveals the COL11A1+ fibroblasts are cancer-specific fibroblasts that promote tumor progression},
  journal = {Frontiers in Pharmacology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphar.2023.1121586}
}
Kostenlos starten →